Santhera Pharmaceuticals Holding AG (SWX:SANN)
Switzerland · Delayed Price · Currency is CHF 17.60
+0.30 (1.73%)
May 13, 2026, 5:31 PM CET
SWX:SANN Market Cap
SWX:SANN has a market cap or net worth of 241.29 million as of May 13, 2026. Its market cap has increased by 31.75% in one year.
Market Cap
241.29M
Enterprise Value
267.80M
Revenue
77.19M
Ranking
n/a
PE Ratio
n/a
Stock Price
17.60
Market Cap Chart
Since November 3, 2006, SWX:SANN's market cap has decreased from 357.28M to 241.29M, a decrease of -32.46%. That is a compound annual growth rate of -1.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 12, 2026 | 241.29M | 43.24% |
| Dec 30, 2025 | 168.45M | 0.68% |
| Dec 30, 2024 | 167.31M | 85.24% |
| Dec 29, 2023 | 90.32M | 19.92% |
| Dec 30, 2022 | 75.32M | 34.92% |
| Dec 30, 2021 | 55.82M | 3.51% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bachem Holding AG | 5.79B |
| Idorsia | 1.09B |
| Basilea Pharmaceutica AG | 684.64M |
| Newron Pharmaceuticals | 283.01M |
| BioVersys AG | 157.31M |
| Xlife Sciences AG | 118.81M |
| Molecular Partners AG | 117.47M |
| MindMaze Therapeutics Holding | 56.92M |